IP Library Granted Patent US 9,612,250
Granted Patent B2
US 9,612,250 · App. 14/350,265 · Granted Apr 4, 2017

Method for the direct detection and/or quantification of at least one compound with a molecular weight of at least 200

Inventors: Joan Perello Bestard (Palma de Mallorca, ES); Ciriaco Maraschiello de Zuani (Barcelona, ES); Irene Lentheric (Barcelona, ES); Paula Mendoza de las Heras (Barcelona, ES); Fernando Tur Espinosa (Palma de Mallorca, ES); Eva Tur Tur (Palma de Mallorca, ES); Maximo Encabo Alarcon (Barcelona, ES); Eva Martin Becerra (Palma de Mallorca, ES); Maria de Mar Benito Amengual (Palma de Mallorca, ES); Bernat Isern Amengual (Palma de Mallorca, ES)
Assignee: Laboratorios Sanifit, S.L.
G01N33/94G01N33/50G01N33/5005G01N33/5308G01N2496/00G01N2560/00Y10T436/163333
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,612,250
App. No.
14/350,265
Granted
Apr 4, 2017
Kind
B2
Abstract

The present invention relates to method for the direct detection and/or quantification of at least one compound with a molecular weight of at least 200, wherein the compound to be detected and/or quantified is a chemically complex molecule, wherein said chemically complex molecule is substituted with at least two groups —R, wherein each R group means independently —OH, —OP(O)(OH)2 or —P(O)(OH)2, with the proviso that at least two R are independently selected from —P(O)(OH)2 and —OP(O)(OH)2, wherein the compound or compounds to be detected and/or quantified are within a biological matrix, wherein said biological matrix is a biological fluid, a biological tissue, stomach contents, intestine contents, stool sample or a culture cells, wherein the method comprises performing a chromatography and identifying the retention time and/or the intensity of the signal by means of a mass or radioactivity detector.

Claims (22)

1. A method for the direct identification and quantification of at least one phosphorus containing compound having a molecular weight of at least 200 daltons in a biological sample

wherein said biological sample is obtained from a biological fluid selected from the group consisting of blood, plasma, serum, urine, saliva, lymphatic liquid, cerebrospinal fluid and combinations thereof, wherein said biological fluid has been treated with a precipitating agent, a chelating agent, or a combination thereof,

wherein said at least one phosphorus containing compound to be identified and quantified in the biological sample is selected from:

(a) a bisphosphonate or polyphosphonate;

(b) a hexametaphosphate;

(c) a C3-C7 cycloalkyl substituted compound with at least two —R groups wherein each —R group is —OH, —OP(O)(OH) 2 or —P(O)(OH) 2 , and wherein at least two —R groups are independently selected from —P(O)(OH) 2 and —OP(O)(OH) 2 and said C3-C7 cycloalkyl is cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, or cyclohelptyl;

(d) ions or salts thereof; or,

(e) a combination thereof,

said method comprising:

(i) preparing at least one standard sample of a phosphorus containing compound to be identified and quantified;

(ii) preparing a biological sample containing the at least one phosphorus containing compound to be identified and quantified, wherein the process to prepare said biological sample comprises at least partially or totally dissolving said biological sample to form a solution or a slurry containing the compound;

(iii) introducing the at least one standard sample together or sequentially with the biological sample into a stream of a solvent system, wherein the solvent system is a polar solvent or a solvent mixture comprising at least one polar solvent and passing the samples through at least one chromatography column containing small particles of resin wherein the column is essentially filled of the small particles in a stationary phase while maintaining the pressure of the system in the chromatography column between 5 and 1500 atm;

(iv) identifying the retention time and/or quantifying the intensity of the signal of the at least one phosphorus containing compound to be identified and quantified by means of a mass spectrometry detector when the samples are eluted from the chromatography column;

wherein in said direct identification and quantification of the at least one phosphorus containing compound in said biological sample is not radiolabeled or derivatized.

2. The method according to claim 1 , wherein the C3-C7 cycloalkyl substituted compound is an inositol polyphosphate comprising from 2 to 6 phosphate groups.

3. The method according to claim 2 , wherein the inositol polyphosphate is phytate.

4. The method according to claim 1 , wherein the biological fluid is an isolated sample obtained from a human subject who is under a bioequivalence study.

5. The method according to claim 1 , wherein the method is used to identify and quantify any metabolites of the at least one phosphorus containing compound in a metabolic profile.

6. The method according to claim 1 , wherein the pH of the solvent system is between 7 and 14.

7. The method according to claim 1 , wherein the mass spectrometry detector is a tandem mass spectrometer, a triple quadrupole spectrometer, or a single quadrupole spectrometer.

8. The method according to claim 1 , wherein the mass spectrometry detector operates under selected ion monitoring (SIM) mode, multiple reaction monitoring (MRM) mode, selected reaction monitoring (SRM) mode, SCAN (positive/negative), or a combination thereof.

9. The method according to claim 1 , wherein the standard sample is a reference standard, an external standard, an internal standard, or an standard addition.

Assignments (3)
NUNC PRO TUNC ASSIGNMENT Recorded Jul 8, 2025
From: SANIFIT THERAPEUTICS, S.A.
To: VIFOR (INTERNATIONAL) LTD.
Reel/Frame 071859/0562 →
CHANGE OF NAME Recorded Jun 5, 2019
From: LABORATORIS SANIFIT S.L.
To: SANIFIT THERAPEUTICS S.A.
Reel/Frame 051483/0468 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 22, 2014
From: PERELLO BERSTARD, JOAN; MARASCHIELLO DE ZUANI, CIRIACO; LENTHERIC, IRENE; MENDOZA DE LAS HERAS, PAULA; ESPINOSA, FERNANDO TUR; TUR TUR, EVA; ENCABO ALARCON, MAXIMO; BECERRA, EVA MARTIN; DE MAR BENITO AMENGUAL, MARLA; ISERN AMENGUAL, BERNAT
To: LABORATORIOS SANIFIT, S.L.
Reel/Frame 033366/0241 →
Priority Claims (1)
EP 11382314 · Oct 6, 2011 · regional
Continuity (1)
Related Publication 20150212101A1 · Jul 30, 2015